Health Care Providers and Services Stocks under Review - Community Health Systems, Tenet Healthcare, UnitedHealth, Molina Healthcare, and Cigna

Editor Note: For more information about this release, please scroll to bottom.

LONDON, October 6, 2014 /PRNewswire/ --

Investor-Edge has initiated coverage on the following equities: Community Health Systems Inc. (NYSE: CYH), Tenet Healthcare Corporation (NYSE: THC), UnitedHealth Group Inc. (NYSE: UNH), Molina Healthcare Inc. (NYSE: MOH), and Cigna Corporation (NYSE: CI). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Friday, October 3, 2014, the NASDAQ Composite ended at 4,475.62, up 1.03%, the Dow Jones Industrial Average advanced 1.24%, to finish the day at 17,009.69, and the S&P 500 closed at 1,967.90, up 1.12%. The gains were broad based as all the sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 745.09, up 1.97%, with the index also advancing 3.29% in the previous three months. Register for your complimentary reports on these five stocks at:  

http://investor-edge.com/register

Community Health Systems Inc.'s stock finished Friday's session 1.67% higher at $55.49. A total of 1.75 million shares were traded, which was above its three months average volume of 1.60 million shares. The stock moved between $54.23 and $55.80 during the session. Over the last one month and the previous three months, Community Health Systems Inc.'s shares have surged 6.08% and 22.01%, respectively. Additionally, from the beginning of 2014, the stock has gained an upside of 41.30%. The company's shares are trading above their 50-day and 200-day moving averages. Moreover, the stock's 50-day moving average of $52.53 is greater than its 200-day moving average of $43.51. Community Health Systems Inc.'s stock traded at a PE ratio of 46.87 and has a Relative Strength Index (RSI) of 54.60. Sign up and read the free notes on CYH at:

www.Investor-Edge.com/CYH-06Oct2014

On Friday, shares in Tenet Healthcare Corp. fluctuated between $58.20 and $59.65 before ending the session 1.19% higher at $58.84. The stock reported a trading volume of 1.97 million shares, above its three months average volume of 1.60 million shares. Shares of the company traded at a PE ratio of 52.05. Tenet Healthcare Corp.'s shares have advanced 1.96% in the last one month, 23.23% in the previous three months and 39.70% on YTD basis. The company's stock is trading above its 200-day moving average of $48.26. Moreover, shares of Tenet Healthcare Corp. have an RSI of 44.89. The complimentary notes on THC can be downloaded as in PDF format at:

www.Investor-Edge.com/THC-06Oct2014

UnitedHealth Group Inc.'s stock advanced 1.32%, to close the day at $86.02. The stock recorded a trading volume of 3.11 million shares, below its three months average volume of 3.46 million shares. The stock oscillated between $85.07 and $86.28 during the session. Over the last three months and since the start of this year, UnitedHealth Group Inc.'s shares have gained 3.20% and 14.24%, respectively. However, the stock has lost 0.27% in the last three trading sessions. The company's stock is trading above its 50-day and 200-day moving averages. The stock's 50-day moving average of $84.79 is above its 200-day moving average of $79.39. Additionally, UnitedHealth Group Inc. traded at a PE ratio of 16.20 and has an RSI of 49.75. Register for free on Investor-Edge and access the latest research on UNH at:

www.Investor-Edge.com/UNH-06Oct2014

On Friday, shares in Molina Healthcare Inc. recorded a trading volume of 0.58 million shares, lower than its three months average volume of 0.71 million shares. The stock ended the day at $42.69, which was 1.16% above its previous day's closing of $42.20, and registered an intraday range of $42.02 and $43.09. Shares of the company traded at a PE ratio of 196.17. Although Molina Healthcare Inc.'s shares have lost 8.09% in the last one month, it has advanced 0.92% in the previous three trading sessions and 22.85% on YTD basis. The company's stock is trading above its 200-day moving average of $40.30. Furthermore, shares of Molina Healthcare Inc. have an RSI of 41.82. The complete research on MOH is available for free at:

www.Investor-Edge.com/MOH-06Oct2014

Cigna Corp.'s stock gained 2.11%, to close Friday's session at $90.59, after oscillating between $89.02 and $90.94. The stock recorded a trading volume of 2.64 million shares, above its three months average volume of 1.42 million shares. Cigna Corp.'s shares have declined 0.11% in the previous three trading sessions and 3.28% in the last three months. However, from the beginning of 2014, the stock has gained 3.56%. The company's stock is trading above its 200-day moving average. The stock's 50-day moving average of $93.00 is above its 200-day moving average of $87.26. Further, the stock traded at a PE ratio of 12.84 and has an RSI of 42.48. Free in depth research on CI is available at:

www.Investor-Edge.com/CI-06Oct2014

About Investor-Edge.com 

At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

===============

EDITOR'S NOTES:

===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.


SOURCE Investor-Edge

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Roche is steamrolling with Ocrevus, and to maintain that lead, its touting long-term data that show the earlier it’s given, the better patients do.

New data shows a significant reduction in relapse rates in patients taking Novartis' repurposed cancer drug ofatumumab.